SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-013571
Filing Date
2020-05-28
Accepted
2020-05-28 09:25:15
Documents
18
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea122415-6k_enlivextherap.htm 6-K 16160
2 PRESS RELEASE ISSUED BY ENLIVEX THERAPEUTICS LTD. ON MAY 28, 2020 ea122415ex99-1_enlivex.htm EX-99.1 17227
3 SLIDE PRESENTATION ea122415ex99-2_enlivex.htm EX-99.2 12579
4 GRAPHIC ex99-1_001.jpg GRAPHIC 9459
5 GRAPHIC ex99-2_001.jpg GRAPHIC 115727
6 GRAPHIC ex99-2_002.jpg GRAPHIC 67382
7 GRAPHIC ex99-2_003.jpg GRAPHIC 353524
8 GRAPHIC ex99-2_004.jpg GRAPHIC 268497
9 GRAPHIC ex99-2_005.jpg GRAPHIC 161937
10 GRAPHIC ex99-2_006.jpg GRAPHIC 126152
11 GRAPHIC ex99-2_007.jpg GRAPHIC 190449
12 GRAPHIC ex99-2_008.jpg GRAPHIC 165664
13 GRAPHIC ex99-2_009.jpg GRAPHIC 171322
14 GRAPHIC ex99-2_010.jpg GRAPHIC 274977
15 GRAPHIC ex99-2_011.jpg GRAPHIC 334098
16 GRAPHIC ex99-2_012.jpg GRAPHIC 294522
17 GRAPHIC ex99-2_013.jpg GRAPHIC 350811
18 GRAPHIC ex99-2_014.jpg GRAPHIC 358831
  Complete submission text file 0001213900-20-013571.txt   4513418
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 20917732
SIC: 2834 Pharmaceutical Preparations